BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1009209)

  • 1. [Age changes in the allosteric properties of brain acetylcholinesterase].
    Miliutin AA; Okun' IM; Aksentsev SL; Arinchin NI; Konev SV
    Biofizika; 1976 Nov; 21(6):1120-2. PubMed ID: 1009209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of membrane-bound acetylcholinesterase in guinea pig and rabbit brains].
    Miliutin AA; Aksentsev SL; Baraĭ VN; Arinchin NI; Konev SV
    Biofizika; 1975; 20(4):638-41. PubMed ID: 1201297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of procaine and d-tubocurarine on the activity of membrane bound acetylcholinesterase.
    Foidart JM; Gridelet J
    Biochem Pharmacol; 1974 Feb; 23(3):725-33. PubMed ID: 4822752
    [No Abstract]   [Full Text] [Related]  

  • 4. [The structural catalytic characteristics of brain acetylcholinesterase in rabbit postnatal ontogeny].
    Podosinovikova NP; Dolgo-Saburov VB
    Zh Evol Biokhim Fiziol; 1979; 15(1):54-8. PubMed ID: 95840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
    Carr RL; Chambers JE
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent?
    Mortensen SR; Brimijoin S; Hooper MJ; Padilla S
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):46-9. PubMed ID: 9465262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular properties and inhibition kinetics of acetylcholinesterase obtained from rat brain and cockroach ganglion.
    Singh AK
    Toxicol Ind Health; 1990 Dec; 6(6):551-70. PubMed ID: 2097819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
    Eichler J; Anselment A; Sussman JL; Massoulié J; Silman I
    Mol Pharmacol; 1994 Feb; 45(2):335-40. PubMed ID: 8114681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural and functional changes in the synaptic membranes of the brain during aging].
    Miliutin AA; Beliaeva EI; Bulanova KIa; Kiriliuk AP; Lyskova TI
    Biofizika; 1984; 29(4):640-2. PubMed ID: 6091786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puromycin as an inhibitor of rat brain acetylcholinesterase.
    Moss DE; Moss DR; Fahrney D
    Pharmacol Biochem Behav; 1974; 2(2):271-5. PubMed ID: 4829603
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of aging on nerve conduction block induced by bupivacaine and procaine in rats.
    Yee TC; Kalichman MW
    J Peripher Nerv Syst; 1997; 2(2):175-9. PubMed ID: 10959231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
    Milatovic D; Dettbarn WD
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
    Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase.
    MacFarlane MD
    Fed Proc; 1975 Jan; 34(1):108-10. PubMed ID: 1109354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin E treatment on N-methyl-D-aspartate receptor at different ages in the rat brain.
    Martínez Villayandre B; Paniagua MA; Fernández-López A; Chinchetru MA; Calvo P
    Brain Res; 2004 Dec; 1028(2):148-55. PubMed ID: 15527740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro cholinesterase inhibitor property of the antitumor agent caracemide.
    Buccafusco JJ; Smith MD
    Res Commun Chem Pathol Pharmacol; 1990 Feb; 67(2):219-27. PubMed ID: 2333410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase.
    Roufogalis BD; Quist EE
    Mol Pharmacol; 1972 Jan; 8(1):41-9. PubMed ID: 5062233
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiolabeling of the rat P2X4 purinoceptor: evidence for allosteric interactions of purinoceptor antagonists and monovalent cations with P2X purinoceptors.
    Michel AD; Miller KJ; Lundström K; Buell GN; Humphrey PP
    Mol Pharmacol; 1997 Mar; 51(3):524-32. PubMed ID: 9058609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of sinapine on activity of acetylcholinesterase in cerebral homogenate and blood serum of rats].
    He L; Li HT; Guo SW; Liu LF; Qiu JB; Li F; Cai BC
    Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(7):813-5. PubMed ID: 18589789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
    Costa LG; Murphy SD
    J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.